Sign In to Follow Application
View All Documents & Correspondence
View All Documents & Correspondence
“Mineralocorticoid Receptor Antagonist And Methods Of Use”
Abstract: The present invention provides a compound of the formula: or a pharmaceutically acceptable salt thereof; pharmaceutical compositions comprising Compound (I) in combination with a suitable carrier, diluent, or excipient; and methods for treating physiological disorders, particularly congestive heart failure, hypertension, diabetic nephropathy, or chronic kidney disease, comprising administering Compound (I), or a pharmaceutically acceptable salt thereof.
Get Free WhatsApp Updates!
Notices, Deadlines & Correspondence
Notices, Deadlines & Correspondence
Patent Information
Application #
Filing Date
09 August 2011
Publication Number
48/2012
Publication Type
INA
Invention Field
CHEMICAL
Status
Email
Parent Application
Applicants
ELI LILLY AND COMPANY
Lilly Corporate Center Indianapolis Indiana 46285 United States of America
Inventors
1. COATES David Andrew
Eli Lilly and Company Lilly Corporate Center Indianapolis Indiana 46285 United States of America
2. GAVARDINAS Konstantinos
Eli Lilly and Company Lilly Corporate Center Indianapolis Indiana 46285 United States of America
3. JADHAV Prabhakar Kondaji
Eli Lilly and Company Lilly Corporate Center Indianapolis Indiana 46285 United States of America
Specification
PLEASE SEE THE SPECIFICATION ATTACHED.
Documents
Application Documents
| # | Name | Date |
|---|---|---|
| 1 | 5747-CHENP-2011 FORM-18 12-08-2011.pdf | 2011-08-12 |
| 1 | 5747-CHENP-2011-AbandonedLetter.pdf | 2017-07-19 |
| 2 | 5747-CHENP-2011-FER.pdf | 2016-10-24 |
| 2 | 5747-CHENP-2011 CORRESPONDENCE OTHERS 12-08-2011.pdf | 2011-08-12 |
| 3 | Form-5.pdf | 2011-09-04 |
| 3 | 5747-CHENP-2011-Correspondence-160915.pdf | 2015-11-27 |
| 4 | Form-3.pdf | 2011-09-04 |
| 4 | 5747-CHENP-2011-OTHERS-160915.pdf | 2015-11-27 |
| 5 | IP17775-Form 1.pdf | 2015-05-05 |
| 5 | Form-1.pdf | 2011-09-04 |
| 6 | IP17775-From 13.pdf | 2015-05-05 |
| 6 | 5747-CHENP-2011 FORM-3 07-02-2012.pdf | 2012-02-07 |
| 7 | 5747-CHENP-2011 FORM-13 01-05-2015.pdf | 2015-05-01 |
| 7 | 5747-CHENP-2011 CORRESPONDENCE OTHERS 07-02-2012.pdf | 2012-02-07 |
| 8 | abstract5747-CHENP-2011.jpg | 2012-09-25 |
| 9 | 5747-CHENP-2011 FORM-13 01-05-2015.pdf | 2015-05-01 |
| 9 | 5747-CHENP-2011 CORRESPONDENCE OTHERS 07-02-2012.pdf | 2012-02-07 |
| 10 | 5747-CHENP-2011 FORM-3 07-02-2012.pdf | 2012-02-07 |
| 10 | IP17775-From 13.pdf | 2015-05-05 |
| 11 | IP17775-Form 1.pdf | 2015-05-05 |
| 11 | Form-1.pdf | 2011-09-04 |
| 12 | Form-3.pdf | 2011-09-04 |
| 12 | 5747-CHENP-2011-OTHERS-160915.pdf | 2015-11-27 |
| 13 | Form-5.pdf | 2011-09-04 |
| 13 | 5747-CHENP-2011-Correspondence-160915.pdf | 2015-11-27 |
| 14 | 5747-CHENP-2011-FER.pdf | 2016-10-24 |
| 14 | 5747-CHENP-2011 CORRESPONDENCE OTHERS 12-08-2011.pdf | 2011-08-12 |
| 15 | 5747-CHENP-2011-AbandonedLetter.pdf | 2017-07-19 |
| 15 | 5747-CHENP-2011 FORM-18 12-08-2011.pdf | 2011-08-12 |
Search Strategy
| 1 | ss_19-10-2016.pdf |